Table 2.
Baseline and follow-up values of peripheral concentrations (given in pg/ml, exceptional for HMGB-1 ng/ml) of pro- and anti-inflammatory mediators
| Pat. no. | HMGB1_bs | HMGB1_as | IL-1β_bs | IL-1β_as | TNFα_bs | TNFα_as | IL-6_bs | IL-6_as | IL-10_bs | IL-10_as |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.956 | 2.368 | 0.136 | 0.065 | 2.414 | 2.318 | 2.759 | 2.083 | 22.667 | 0.000 |
| 2 | 5.897 | 5.574 | 0.140 | 0.070 | 2.136 | 2.291 | 3.524 | 6.800 | 32.000 | 0.000 |
| 3 | 1.838 | 4.309 | 0.117 | 0.201 | 1.886 | 1.886 | 2.566 | 4.455 | 25.333 | 0.000 |
| 4 | 4.397 | 2.691 | 0.229 | 0.089 | 1.259 | 1.350 | 3.862 | 0.897 | 40.000 | 16.667 |
| 5 | 38.691 | 5.338 | 0.369 | 0.201 | 1.914 | 1.986 | 12.041 | 2.855 | 0.667 | 14.667 |
| 6 | 4.515 | 2.897 | 0.014 | 0.056 | 0.986 | 1.059 | 2.490 | 1.793 | 0.667 | 0.000 |
| 7 | 6.868 | 4.338 | 0.336 | 0.350 | 1.877 | 1.918 | 15.462 | 17.614 | 7.333 | 24.000 |
| 8 | 9.132 | 1.544 | 0.140 | 0.103 | 1.545 | 1.500 | 4.462 | 3.359 | 76.000 | 10.667 |
| 9 | 2.485 | 1.662 | 0.121 | 0.093 | 1.605 | 1.818 | 2.090 | 1.352 | 94.000 | 1.333 |
| 10 | 9.868 | 11.838 | 0.103 | 0.131 | 1.936 | 1.236 | 12.903 | 16.193 | 59.333 | 4.667 |
| 11 | 3.603 | 4.544 | 0.131 | 0.173 | 1.423 | 1.477 | 2.566 | 5.690 | 60.667 | 6.000 |
| 12 | 2.544 | 4.397 | 0.065 | 0.150 | 1.691 | 1.709 | 2.538 | 3.407 | 38.000 | 13.333 |
| Pat. no. | Ghrelin_bs | Ghrelin_as | Adiponectin_bs | Adiponectin_as | Leptin_bs | Leptin_as | BDNF_bs | BDNF_as | Oxytocin_bs | Oxytocin_as |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3895.376 | 5059.584 | 10,670 | 11,340 | 258,300 | 219,500 | 45,790.48 | 53,552.38 | 39.7 | 59.9 |
| 2 | 2622.864 | 2387.712 | 8610 | 8200 | 11,100 | 17,000 | 44,266.67 | 44,933.33 | 33.7 | 42.5 |
| 3 | 4873.856 | 3762.032 | 4440 | 4190 | 70,600 | 75,200 | 34,838.10 | 23,266.67 | 22.5 | 49.5 |
| 4 | 4134.976 | 13045.936 | 8730 | 19,330 | 49,800 | 28,200 | 29,457.14 | 41,409.52 | 31.3 | 15 |
| 5 | 4203.376 | 3793.04 | 2110 | 4300 | 5600 | 7400 | 54,838.10 | 47,361.90 | 15 | 111.2 |
| 6 | 6972.928 | 8809.568 | 8760 | 12,500 | 23,800 | 7700 | 23,076.19 | 33,980.95 | 23.9 | 87.6 |
| 7 | 2374.272 | 2223.344 | 6860 | 3460 | 40,500 | 85,000 | 34,266.67 | 36,504.76 | 20.7 | 15 |
| 8 | 2858.688 | 2493.792 | 1650 | 1300 | 63,000 | 56,100 | 27,742.86 | 29,933.33 | 23.1 | 116.1 |
| 9 | 14,335.92 | 12126.912 | 10,620 | 7230 | 54,300 | 45,800 | 41,171.43 | 39,266.67 | 28.7 | 15 |
| 10 | 10885.504 | 5767.136 | 7800 | 6270 | 45,300 | 47,900 | 35,314.29 | 42,076.19 | 15 | 17.5 |
| 11 | 4144.784 | 4280.784 | 28,850 | 22,450 | 31,800 | 36,000 | 49,742.86 | 34,647.62 | 61.4 | 24.6 |
| 12 | 2387.712 | 1824.88 | 4250 | 3610 | 135,000 | 105,900 | 52,600.00 | 37,457.14 | 39.5 | 119.1 |
Gravius et al. [1]
bs, before stimulation; as, after 3 months L4-DRGSTIM